Biomedical data analysis is transforming medicine. Through the growth of genomic, imaging, sensor, and other data, healthcare is becoming more predictive, personalized, and precise. Curoverse is dedicated to providing the open source enabling technology to accelerate this transformation. By addressing the data and compute infrastructure software challenges in the biomedical field, we empower scientists and clinicians to focus on what they do best: making breakthrough discoveries and delivering real-world care. Curoverse is an investor-backed private company based in Boston, Massachusetts.